Synthesis, spectral elucidation, antibacterial, antioxidant and DNA studies of ONNO tetradentate Schiff base metal(II) complexes derived from Benzene-1,4-dicarboxaldehyde by savitha, kumarasamy  & Vedanayaki, Subramaniam 
Indian Journal of Chemistry 
Vol. 60A, May 2021, pp. 682-691 
Synthesis, spectral elucidation, antibacterial, antioxidant and DNA studies of 
ONNO tetradentate Schiff base metal(II) complexes derived from  
Benzene-1,4-dicarboxaldehyde 
Kumarasamy Savitha & Subramaniam Vedanayaki* 
Department of Chemistry, Kandaswami Kandar’s College, ParamathiVelur (TK), Tamil Nadu 638 182, India 
*E-mail: ksavitha39@gmail.com (KS)/ varshuvishal@gmail.com (SV)
Received 18 December 2019; revised and accepted 10 February 2021 
The new dibasic tetradentate (ONNO) Schiff base ligands (L1and L2) have been synthesized by the reaction of 
terephthalaldehyde with 2-amino 4-chlorophenol and X (where, X=2-amino 4-methylphenol, 2-aminophenol) in 1:1:1 molar 
ratio. The macrocyclic binuclear Co(II), Ni(II) and Cu((II) metal complexes are prepared in ligand to metal ratio 2:2. 
The elements, metal structure and binding sites of Schiff bases and its complexes are established by diverse studies like 
elemental, molar conductance, UV, magnetic moment, FT-IR, H1 and C13 NMR, ESI-mass, ESR, thermal and powder-XRD. 
The spectral studies reveal that the ligands are tetradentate and its metal complexes possess a square planar geometry. All 
the compounds are screened for antibacterial, antioxidant and DNA cleavage and the results show high activity for metal 
complexes than the ligand. The DNA binding studies of Cu(II) complexes were measured by electronic absorption method. 
In vitro cytotoxicity assay of Cu(II) complexes have been tested for their tumour inhibiting potential against MCF-7 human 
breast cancer cell by using MTT method. 
Keywords: Schiff bases, Square planar, Antimicrobial, Antioxidant, DNA studies, Antitumour activity 
Schiff base ligands played central role as chelating 
ligands in the main group. Chelating Schiff bases 
having mono, di and polydentate donor atoms of O, N 
and S show biological activity and these chelating 
ligands are very useful for organometallic chemistry. 
It is bound to metal ions and Schiff base metal 
complexes give small changes in the geometry which 
depends upon its ligand having hard and soft donor 
atoms
1,2
. N2O2, NNNN and ONO donor atoms of
polydentate ligands give stable complexes with 
transition metal ions due to their close proximity of 
the donor sites and it gives four, five and six member 
chelate rings. Symmetrical diimines (~N=HC-Ar-
CH=N~ (or) ~HC=N-Ar-N=CH~) formed from the 
condensation of one mole of an aromatic diamine and 
two moles of aldehyde (or) one mole of an aromatic 
dialdehyde and two moles of primary amine was 
prepared directly. Schiff base including two different 
imino groups attached to the same aromatic ring form 
an asymmetric diimine (~N=HC-Ar-N=CH~). 
Recently many literatures concerning synthesis of 
asymmetrical diimines have been published
3
. 
Biological applications of Schiff base complexes are 
one of the most completely studied topic in 
coordination chemistry due to its best activities than 
the non-Schiff base metal complexes
4,5
. Schiff base 
metal complexes have an extensively diverse structure 
from the coordination of metal with either mono-, bi-, 
tri and tetra dentate ligand which is depends upon the 
carbonyl groups and amines. The asymmetrical 
tetradentate ligand complexes have been used as 
catalyst in some chemical process and suggested as 
very useful biological kinds in understanding no 
regular interaction of peptides
6
. Schiff base ligands 
are resulted in small changes in its structure can affect 
significantly their antiprolifer active activity and 
considerable cytotoxicity activities due to its varied 
structure
7
. Schiff base transition metal complexes has 
more strong properties of structural, chemical and 
spectral character depends upon the nature of its 




Schiff bases, containing the imine group (C=N) as 
the central structural form, have been the subject of 
prevalent research in the various field of chemical 
industry as these are used as model analogues of 
certain metal enzymes. In recent years, metal-based 
drugs act very important role in medicinal field such 
as drugs for the cancer treatment, diabetes, 
cardiovascular diseases and anti-inflammatory
10,11
. 




Transition metal complexes of 2-aminophenol based 
compounds have vast application fields in 
antidepressants, antiphlogogistic, nematocide and 
other medicinal agents
12
. Schiff base complexes are 
widely studied due to synthetic flexibility, selective 
and sensitivity towards a diversity of organisms, 
potential application in fields like as oxidation 
catalysis, analytical and electrochemistry, dye & food 
industry, agrochemical and pharmaceutical fields
13-15
. 
Intramolecular hydrogen bonding between hydroxyl 
group (OH) hydrogen and imino group (CH=N) 
nitrogen atoms of the Schiff base and their metal 
complexes plays a considerable role in many fields of 
anti-tubercular, anti-HIV, anthelmintic, anti-amoebic, 
antinociceptive, antimouse hepatitis virus (MHv), 
inhibition of herps simplex virus type-1(HSV-1), 
adenovirus type-5 (AD-5), antimalarial, pesticidal, 
herbicidal, antipyretic, antiviral, antioxidant, 
antibacterial and antifungal
16-23
. Moreover, copper 
metal is a very important between other transition 
metals and it is the third most abundant metallic 
element in human body following the metals of iron 
and zinc. It plays many roles in the enzyme catalysis, 
necessary for the growth, maintenance and 
development of bones, connectivity tissues, heart, 
brain and many other body organs
24
.  
Based on the above fact, herein we have  
reported the synthesis of new asymmetric Schiff  
base ligands (4-chloro-2-((E)-(4-((E)-((2-hydroxy-5-
methyl phenyl) imino)methyl)benzylidene)amino) 
phenol) (L1) and 4-chloro-2-((E)-(4-((E)-((2-
hydroxyphenyl)imino)methyl)benzylidene)amino- 
phenol (L2) containing the azomethine (CH=N) and 
hydroxyl groups (OH) as potent chelating sites and its 
Co(II), Ni(II) and Cu(II) binuclear metal complexes 
evaluated by diverse physicochemical technique and 
their applications were analyzed for antibacterial, 
antioxidant, DNA studies (cleavage and binding) and 
antitumour activity (in vitro cytotoxicity).  
 
Materials and Methods 
Analytical and physical measurements 
Terephthalaldehyde, 2-amino 4-chlorophenol, 2-
amino 4-methylphenol, 2-aminophenol and metal 
salts were purchased from Sigma Aldrich. Ethanol, 
methanol, dimethyl solphoxide (DMSO), dimethyl 
formamide (DMF) and acetone were purchased from 
Loba and Merck chemicals, respectively. The purity 
of all compounds was tested by thin layer 
chromatography (TLC). C, H and N elements were 
determined on a Thermo Finningan Flash EA 1112 
series elemental analyzer. Molar conductance of the 
compound was measured by ELICO CM 180 
Conductivity Bridge. Magnetic moment values were 
observed using Gouy balance calibrated with 
Hg[Co(SCN)4] experiment. Electronic absorption 
spectrum was measured using Perkin Elmer Lambda -
25 spectrometer. FT-IR spectra were recorded on a 





-NMR spectra were obtained on 
a BRUKER ADVANCED III 400 MHz spectrometer 
using TMS used as reference. ESI-mass spectra were 
recorded on a Perkin- Elmer R MU-6E instrument. 
ESR spectra were measured on JES-FA200 ESR 
spectrometer with X-band frequency. Thermal 
analysis studies were carried out at 0-1000 ºC using 
SDT-Q600 V20.9 Build 20 thermal analyzer. The 
PXRD was recorded on Perkin Elmer TA/SDT-2960 
and Philips 3701 instrument.  
 
Synthesis of asymmetrical tetra dentate Schiff base L1 
(compound 1) 
The mixture of 1 mmol of terephthalaldehyde with 
1 mmol of 2-amino 4-chlorophenol and 1 mmol of  
2-amino 4-methylphenol were dissolved in methanol. 
The solution was kept under stirring for 2 h, the 
formed yellow precipitate was separated by filtration, 
washed and purified by methanol solvent. The Schiff 
base solid was recrystalized from ethanol. Yellow 
solid, Molecular weight: 364.82, Melting point: 240 ºC, 
Yield: 80%, IR (KBr, cm
-1
): 3345 (OH), 1621 (C=N), 
1278 (C-O); 
1
H-NMR (DMSO-d6, δ, ppm): 8.75 (s, 
1H, C=N), 10.1 (s, 1H, OH), 3.4(s, 3H, CH3), 6.9-8.2 
(m, Ar—H); 
13
C-NMR (100 MHz, CDCl3): 112, 113, 
114, 116, 120, 124, 129, 135, 137, 147, 161; 
Elemental analysis (%) of C21H17ClN2O2: calculated 
(found): C, 69.14 (68.86); H, 4.70 (4.50); N, 7.68 




Synthesis of asymmetrical tetra dentate Schiff base L2 
(compound 5) 
The procedure is the same as L1 using 
terephthalaldehyde with 2-amino 4-chlorophenol and 
2-aminophenol. The dark yellow precipitate was 
formed. Molecular weight: 350.08, Melting point:  
250 ºC, Yield: 80%, IR (KBr, cm
-1
): 3346 (OH), 1621 
(C=N), 1369 (C-O); 
1
H-NMR (DMSO-d6, δ, ppm): 
8.80 (s, 1H, C=N), 9.4 (s, 1H, OH), 6.8-7.3 (m, Ar—H); 
13
C-NMR (100 MHz, CDCl3): 110, 115, 116,120, 123, 
124, 126, 127, 128,130, 137, 138, 148, 150, 152; 
Elemental analysis (%) of C20H15ClN2O2: calculated 




(found): C, 68.48 (67.71); H, 4.31 (4.13); N, 7.99 




Synthesis of binuclear metal(II) complexes 
The homo binuclear metal(II) complexes were 
synthesized by using template method
25
. The mixture 
of terephthalaldehyde (2 mmol) with 2-amino  
4-chlorophenol (2 mmol) and X (where, X = 2-amino 
4-methylphenol, 2-aminophenol) (2 mmol) were 
dissolved in methanol, which were added to the 
methanolic solution of metal salts (2 mmol) like Co, 
Ni and Cu. The mixture was stirred and few drops of 
tri ethylamine were added to the mixture. It was 
stirred for 1 h and refluxed for 3 h. The product was 
partly evaporated, cooled at room temperature. The 
obtained metal complexes were separated by 
filtration, washed with methanol and diethyl ether, 
stored in room temperature. The structure of metal 
complexes was show in Scheme 1. 
 
Schiff base binuclear Co(II) complex (compound 2) 
Brownish black solid, Molecular weight: 903.62, 
Melting point: >300 ºC, Yield: 78%, IR (KBr, cm
-1
): 
1606 (C=N), 1384 (C-O), 518 (M-O), 492 (M-N); 
Elemental analysis (%) of C46H42Cl2Co2N4O4: 
calculated (found): C, 61.14 (60.80); H, 4.68 (4.51); 
N, 6.20 (6.18); M, 13.04 (12.98); Molar conductance 
(𝛺-1 cm2 mol-1) 10.6. 
 
Schiff base binuclear Ni(II) complex (compound 3) 
Reddish yellow solid; Molecular weight: 903.14; 
Melting point: >300 ºC; Yield: 76%; IR (KBr, cm
-1
): 
1565 (C=N), 1385 (C-O), 515 (M-O), 467 (M-N); 
Elemental analysis (%) of C46H42Cl2N4Ni2O4: 
calculated (found): C, 61.17 (61.12); H, 4.69 (4.53); 
N, 6.20 (6.21); M, 13.00 (12.81); Molar conductance 
(𝛺 -1 cm2 mol-1) 11.3. 
 
Schiff base binuclear Cu(II) complex (compound 4) 
Black solid; Molecular weight: 912.85; Melting 
point: >300 ºC; Yield: 79%; IR (KBr, cm
-1
): 1601 
(C=N), 1397 (C-O), 513 (M-O), 462 (M-N); 
Elemental analysis (%) of C46H42Cl2Cu2N4O4: 
calculated (found): C, 60.52 (60.35); H, 4.64 (4.55); 
N, 6.14 (6.04); M, 13.92 (13.82); Molar conductance 
(𝛺 -1 cm2 mol-1) 13.5. 
 
Schiff base binuclear Co(II) complex (compound 6) 
Wine red solid; Molecular weight: 875.57; Melting 
point: >300 ºC; Yield: 79%; IR (KBr, cm
-1
): 1601 
(C=N), 1385 (C-O), 583 (M-O), 468 (M-N); 
Elemental analysis (%) of C44H38Cl2Co2N4O4: 
calculated (found): C, 60.36 (59.81); H, 4.37 (4.17); 
N, 6.40 (6.30); M, 13.46 (13.25); Molar conductance 
(𝛺 -1 cm2 mol-1) 10.3. 
 
Schiff base binuclear Ni(II) complex (compound 7) 
Yellowish brown solid; Molecular weight: 875.09; 
Melting point: >300 ºC; Yield: 75%; IR (KBr, cm
-1
): 
1583 (C=N), 1383 (C-O), 598 (M-O), 443 (M-N); 
Elemental analysis (%) of C44H38Cl2N4Ni2O4: 
calculated (found): C, 60.39 (60.15); H, 4.38 (4.19); 
N, 6.4 (6.30); M, 13.41 (13.19); Molar conductance 
(𝛺 -1 cm2 mol-1) 11.7. 
 
Schiff base binuclear Cu(II) complex (compound 8) 
Black solid; Molecular weight: 884.79; Melting 
point: >300 ºC, Yield- 78%; IR (KBr, cm
-1
): 1572 
(C=N), 1394 (C-O), 581 (M-O), 477 (M-N); 
Elemental analysis (%) of C44H38Cl2Cu2N4O4: 
calculated (found): C, 58.73 (58.82); H, 4.33 (4.22); 
N, 6.33 (6.21); M, 14.36 (13.10); Molar conductance  




In vitro antibacterial activity was performed by the 
Disc-agar well diffusion experiment. The asymmetric 
 
 
Scheme 1 — Synthesis of metal complexes by template method 




tetradentate Schiff base ligands and their homo 
binuclear complexes were screened against bacteria of 
gram-positive (S. aureus, B. subtillis) and gram-
negative (K. neumoniae, E. coli). Tetracycline was 
used as standard drug for antibacterial activity and the 
tested compounds were dissolved in DMSO. The 
antibacterial activities were maintained in nutrient 
agar well plates at 4 ºC. The 100 µL concentration of 
culture supernatant was placed on agar well plate and 
then it was incubated for 24 h at 37 ºC. The 
antibacterial activity was determined by measuring 






Schiff base ligands (compound: 1, 5) and their 
metal (compounds: 2, 3, 4, 6, 7, 8) complexes were 
investigated by using its free radical scavenging 
activity on the stable DPPH free radicals described in 
the literature
27
. The scavenging activity investigates 
the antiradical power of an antioxidant by calculating 
the decrease in the absorbance wavelength of DPPH 
at 510 nm. The ligands and its metal complexes 
exhibit DPPH free radical scavenging activity at 
different concentrations (like as 10, 20, 30, 40 and  
50 µL). The percentage of DPPH free radical 
scavenging ability was measured by using the 
following formula, 
 
𝐼  % =  (𝐴𝑐 − 𝐴𝑠) 𝐴𝑐 × 100   
 
where, 𝐴𝑐  and 𝐴𝑠 are the absorbance of the control 
and tested sample, respectively. IC50 values were 
calculated for ligand and its complexes, which 
showed the significant ability and it is defined as 
concentration sufficient to generate 50% of maximum 
scavenging activity. Ascorbic acid was used as 
standard. 
 
DNA binding studies 
Electronic absorption spectroscopy 
Electron absorption spectroscopy is one of the most 
useful technique to determine the interaction between 
the metal complexes with DNA from the stock 
solution of calf thymus (CT)
28
. DNA was prepared by 
5 mM Tris-HCL/20 mM NaCl buffer (p
H
=7.2) at 
room temperature. The stock solution was stored at  
4 ºC and used up to 4 days. The buffer solution of  
CT- DNA gave a ratio of ~1.8-1.9 and the absorbance 
at 260 to 280 nm. The concentration of CT-DNA was 
determined using the known molar extinction 




 at absorption 
intensity is 260 nm. The stock solution concentrations 
of the complexes were prepared by dissolving the 
Cu(II) complexes (compounds 4, 8) in DMSO. All the 
experiments were maintained at proper dilution with 
corresponding buffer to the required concentration. 
The binding constant (Kb) was calculated by using the 
following equation, 
 
[𝐷𝑁𝐴] (𝜀𝑎 − 𝜀𝑓) = [𝐷𝑁𝐴] (𝜀𝑎 − 𝜀𝑓) + 1 𝐾𝑏 (𝜀𝑎 − 𝜀𝑓) 
 
where, [DNA] is molar concentration of DNA in 
base pairs, εa, εf are apparent extinction coefficient, 
the Kb values were obtained from the ratio  
between the equation of DNA/ (εa-εf) versus [DNA] in 
each case. 
 
Agarose gel electrophoresis assay 
The cleavage of super coiled pBR322 DNA was 
investigated by gel electrophoresis method
29
. The 
agarose gel electrophoresis studies were carried out 
incubation of the mixtures containing 20 µL pBR322 
DNA, 50 mM of NaCl, 50 mM of metal complexes 
and 50 mM H2O2 in Tris-HCl buffer (p
H
=7.4) at 37 ºC 
for 1 h. After incubation, the sample compounds were 
electrophoresed at 60 ºC for 2 h on 1% of agarose gel 
using TAE (Tris-Acetic acid-EDTA) buffer (p
H
=8.0). 
After 0.5 µg/mL of ethidium bromide was used, the 
gel was stained. Thus all the experiments were 
performed at room temperature and photographed 
under UV light at 360 nm. 
 
Antitumor activity 
In vitro cytotoxicity was carried out on  
a MCF-7 cell line in which cell viability was tested 
using MTT (3-(4,5-dimethyl thiazol-2-yl)-2,5-
diphenyltetrazolium bromide) activity
30
. In vitro 
effect of growth inhibition of Cu(II) complexes (4, 8) 
were measured by spectrophotometric experiment. 
This experiment was used to determine the MTT 
conversion into ―formazan‖ by living cells and it was 
maintained in a 96-well microplate having 
DMEM/F12 plain media supplemented with 10% heat 
inactivated FBS (Fetal Bovine Serum) having 5% of 
mixture of 100 µg/mL of streptomycin and  
100 units/ml of penicillin were incubated at 37 ºC for 
24 h in the presence of 5% CO2. In this study, various 
concentrations of 10, 20, 40, 80, 160 and 320 µL of 
the stock solution was prepared in DMSO, which 
were added to relevant wells having 100 µL of the 
DMSO medium. After incubation, 100 µL of MTT 
stock solution (5 mg/10 mL of MTT in PBS) was 
added to each well and further incubated for 4 h. After 




the supernatant was removed, the plates were gently 
shaken to form solubilise formazan crystals by adding 
100 µL of DMSO. The absorbance was measured at 
wavelength 590 nm by microplate reader. The activity 
was performed in triplicate and used to calculate  
the mean. 
 
Results and Discussion 
The synthesized ligands and their metal complexes 
were investigated by diverse physicochemical 
methods. The resultant compounds are soluble in 
DMF and DMSO, partially soluble in ethanol and 
methanol. The molar conductance of ligands and their 
complexes were measured at 25 ºC in DMF solution 
(10
-3
 M) indicates low conductance values (10.3 to 





Electronic absorption spectral data 
The UV-visible spectral data of the ligand and its 
complexes were measured within a 200-800 nm 
wavelength at room temperature in DMSO solution. 
In the electronic spectra of the mixed ligands (L1 and L2) 
were exhibit absorption bands at 300, 299 and 392, 
388 nm, which are referred to the aromatic benzene 
rings (𝜋→𝜋*) and imine group (n→𝜋*), 
respectively
33
. The diffuse reflectance spectrum of the 
macrocyclic metal(II) compounds 2, 3,4, 6, 7 and 8 
show bands at 442, 439, 440, 436, 414 and 438 nm, 
which may be attributed to the ligand to metal co-
ordinations (L→M transitions) in square planar 
geometry of the compounds (given in Table 1). The 
magnetic moment and absorption spectra is used to 





IR spectrum is used to investigate of the existence 
of intra molecular hydrogen bonding, the nature of the 
co-ordination mode in the metal complexes and 
presence of the tautomeric forms in the solid states. 
The important vibrational frequency of the free 
ligands (L1 and L2) were exhibited bands at 1621 and 
1621 cm
-1
, which indicates the formation of imine 
groups(C=N)
 35
. However, on complexation this band 
(C=N) is shifted to lower energy range 1606-1565 cm
-1, 
suggesting the participation of the azomethine 
nitrogen atom in co-ordination to the metal ion. The 
sharp broad bands around 3345 and 3346 cm
-1
 in the 
ligands (L1 and L2) were assigned to the phenolic –OH 
groups. The absence of ν(OH) bands in the metal 
complexes, indicates the co-ordination of the ν(OH) 
groups after deprotonation. The ν(C=O) band at 1278 
and 1369 cm
-1
 for L1 and L2 were lower frequency 
than the band at about 1700 cm
-1
 for ν(C=O) , this 
frequency change shows the formation of azomethine 
group(ligand). The appearance of new bands at  
443-492 and 513-598 cm
-1 
in the vibrational spectra of 





. These vibrations were 
clearly suggesting the co-ordination of the metal ions 
with the azomethine nitrogen and phenolic oxygens in 
the complex. 
 




H NMR spectra of the ligands of L1 and L2 
were recorded at 25 ºC (RT) in DMSO-d
6
 solvent with 
TMS as internal standard. The azomethine (CH=N) 
proton signal was obtained at δ 8.75 and δ 8.80 ppm, 
this signal indicates the formation of mixed Schiff 
base ligands (Fig. 1)
37
. The new peaks of phenolic –
OH protons of the aminophenol and aromatic protons 







C- NMR spectra of the synthesized ligands  
(L1 and L2) are shifted to δ 161 and δ 152 ppm for 
azomethine carbon atom. The peaks observed at  
δ 147, δ 150 ppm and δ 112-129, δ 137-110 ppm are 
due to phenolic –OH carbons by aminophenol and 
aromatic benzene ring carbon atoms for ligands L1 
and L2 are shown in Fig. 2. The peaks appeared at  
δ 137, δ 138 ppm are due to substituted Cl atoms by 
aminophenol for L1 and L2. The signal appeared at  
δ 135 ppm was referred to the methyl group of the  





The mass spectra of Schiff base ligands (L1, L2) 
and their copper complexes (compounds 4, 8) as 
Table 1 ― UV absorption data of ligands and their metal(II) 
complexes 
S. No. Compounds 𝜋 − 𝜋 ∗ n→ 𝜋 ∗ L→M Geometry µeff 
(BM) 
1 [L1] 300 392 --- --- --- 
2 [Co2L2] 251 374 442 Square planar 1.82 
3 [Ni2L2] 253 370 439 Square planar --- 
4 [Cu2L2] 252 378 440 Square planar 1.71 
5 [L2] 299 388 --- --- --- 
6 [Co2L2] 271 354 436 Square planar 1.80 
7 [Ni2L2] 251 370 414 Square planar --- 
8 [Cu2L2] 279 369 438 Square planar 1.76 




shown in Supplementary Data, Fig. S1, have 
molecular ion peaks at m/z 365, 351 (M+1)
+
 and 913, 
885 (M+1)
+
, which corresponds to the proposed 
molecular formula of L1 (C21H17ClN2O2), L2 
(C20H15ClN2O2) and their Cu complexes 4 
(C46H42Cl2Cu2N4O4), 8 (C44H38Cl2Cu2N4O4), 
respectively
40
. The mass spectral data of ligands (L1 
and L2) and their copper (II) complexes (compounds 
4, 8) were confirmed by comparing their molecular 
formula weights with (m/z) mass values, which is in 
good agreement for these ligands ( compound 1 and 
5) and Cu (compound 4 and 8) complexes.  
 
Electron paramagnetic resonance spectra 
The electron paramagnetic resonance (epr) studies 
of the Cu(II) complexes (compound 4 and 8) gives 
information about hyperfine and superhyperfine 
structures and about the nature of the bonding 
between the copper ion and their ligand
41
. The epr 
spectra of compound 4(Cu2L2) and compound. 
8(Cu2L2) exhibit an axial symmetry at X-band 
frequencies in the solid state as shown in Fig. 3. The 
obtained g-values are gII = 2.2391, g⟘ = 2.0554 and  
gII = 2.2418, g⟘= 2.0498 for compounds 4 and 8, 
which are related by G=(gII-2)/(g⟘-2)=4.0. If G value 
is more than 4 i.e., (G>4), it indicates no considerable 
exchanging interaction between the two copper 
centers in the complex, whereas if G value is less than 
4 (G<4), it shows that the exchange interaction occurs 
in the solid state complex. From the observed G value 
of Cu(II) complexes are 4.31 and 4.85 for compounds  
 
 




Fig. 2 — C13 -NMR spectra of (a) L1 and (b) L2 
 




4 and 8. It is clear that gII>g⟘>2.0023, which indicates 
dx2-y2 in orbital ground state for square planar structure 
of the Cu(II) complexes 4 and 8.  
 
Thermal studies 
The thermal analysis (TG & DSC) was used to 
determine thermal stability of compounds in the 
presence of air atmosphere at the temperature range 
between 0 to 1000 ºC
42
. Thermograms of the ligands 
(L1 and L2) and their complexes (2, 3, 4, 6, 7 and 8) 
are shown in Supplementary Data, Fig. S2. The both 
TG and DSC analysis of compounds have three steps 
of decomposition process each. The first, second and 
third steps correspond to the elimination of small 
groups of substituted Cl atoms by 2-aminophenol, the 
removal of total ligand moiety and the formation of 
metal oxide residue. 
 
Powder XRD analysis 
The structure of Schiff bases and their binuclear 
metal complexes were investigated using P-XRD 
analysis which indicates the amorphous orthorhombic 
crystal
43
 nature of compounds within the range  
10-90 ºC (2θ) and the wavelength is 1.5406 Å  
(Supplementary Data, Fig. S3). Thus all the 
compounds show crystalline nature from its observed 
peaks. The powder-XRD provides the d-value, 




The antibacterial results showed that the Schiff 
base ligands have very low or no inhibition  
activity compared to their metal complexes
44
. Thus,  
Cu(II) complexes (compounds 4, 8) have  
exhibited higher antibacterial activity than the other  
Co(II) (compounds 2, 6) and Ni(II) (compounds 3, 7) 
complexes. Antibacterial activities of L1 and L2 with 
their metal complexes are shown in Fig. 4. 
 
Antioxidant assay 
DPPH free radical scavenging activity 
The ligands (compounds 1, 2) and their Co(II) 
(compounds 2,6), Ni(II) (compounds 3, 7) and Cu(II) 
(compounds 4, 8) complexes were screened for their 
DPPH free radical scavenging ability using Ascorbic 
acid as standared
4 




Fig. 3 — EPR spectra of Cu(II) complexes: (a) compound 4 and 
(b) compound 4 
 
 
Fig. 4 — Antibacterial activity of (a) ligands (1 and 2) with (b) 
their metal (Co(II), Ni(II) and Cu(II)) complexes 




when compared to all the complexes as shown in  
Fig. 5. The scavenging activity of Cu(II) complexes 
are higher than that of other metal complexes.  
The IC50 values are determined for all compounds  
and the IC50 values of [Cu2 (C46H42N4O4Cl2)] and  
[Cu2 (C44H38N4O4Cl2)] have shown significant  
activity compared to other complexes and  
ligands. The order of scavenging activity of all 
complexes according to their IC50 values is given 
below. 
Ascorbic acid > [Cu(II) complexes] > [Ni(II) 
complexes]> [Co(II) complexes]> ligands 
 
DNA- copper complex interaction studies 
The interactions of CT-DNA and metal complexes 
(4, 8) were determined by the electronic absorption 
spectroscopy technique. From the studies it is 
revealed that the intensity changes of the intra ligand 
𝜋 → 𝜋* transition band occur at 250-280 nm46. The 
UV absorption experiments of Cu(II) complexes 
(compounds 4, 8) in presence of buffer solution are 
performed by using a fixed concentration of complex 
to which increments of the stock solution are added. 
The interaction of [Cu2 (C46H42N4O4Cl2)] and [Cu2 
(C44H38N4O4Cl2)] complexes with duplex DNA led to 
a decrease in the intensities and a small amount of red 
shift in the electronic absorption spectra and the 
concentration of DNA increases with the absorption 
bands of Cu(II) complexes are affected to a 
considerable extent. This absorption spectra indicate 
clearly that the addition of CT-DNA to the Cu(II) 
complexes yields hypochromic and red shift (shown 
in compound 8) to the ratio of [DNA]/[Cu] for the 
compounds 4, 8 complexes and the complexes 
interact with CT-DNA most likely through a binding 
mode that involves 𝜋 → 𝜋* stacking interaction 
between the aromatic chromophore and the base pair 
of DNA as shown in Fig. 6. 
 
H2O2 induced DNA damage/ production assay 
Gel electrophoresis activity is a method to 
determine different binding modes of newly 
synthesized complexes to super coiled pBR322 DNA. 
The natural- derived plasmid pBR322 DNA has three 
forms of closed-circle super coiled form (form-I), 
 
 
Fig. 5 — Antixoidant activity of (a) ligands (1 and 2) with  
(b) their metal (Co(II), Ni(II) and Cu(II)) complexes 
 
 
Fig. 6 — Absorption spectra of Cu complexes (compd. 4 and 8) 




nicked form (form-II) and linear form (form-III)47. 
The circular plasmid DNA is conducted by 
electrophoresis, relatively the fasted migration 
measured for the super coiled form (form-I). If 
cleavage occurs on one strand, the super coils will 
relax to generate slowed moving open circular form 
(form-II). If both of strands are cleaved a form-III 
(linear form), it will be produced that moves in 
between super coiled form and open circular form. 
From the results (Fig. 7), it indicates that the gel 
electrophoretic separation of plasmid pBR322 DNA, 
interaction with metal complexes in the presence of 
H2O2. The addition of the complexes with the mixture 
of form-II and form-III, which form the cleavage of 
super coiled DNA. The reports show that the 
compounds 2, 3, 4, 6, 7 and 8 metal complexes 
induced intensively the cleavage of DNA in the 
presence of H2O2. These observations suggested  
that all dinuclear complexes effectively cleave the 
plasmid pBR322 DNA. 

















10 0.846 14.06  
53.7 20 0.732 25.57 
40 0.578 41.21 
80 0.403 59.04 
160 0.318 67.73 




10 0.812 17.48 84.6 
20 0.702 28.70 
40 0.638 35.21 
80 0.513 47.89 
160 0.387 60.69 
320 0.274 72.12 
 
In vitro cytotoxicic assay 
To determine the cytotoxicity effect, the newly 
synthesized homo binuclear Cu(II) complexes 
(compounds 4, 8) were treated with human breast 
cancer cell line (MCF-7) by MTT experiments 
method48. The absorbance value is lower than the 
control cell which indicates a reduction in the rate of 
cell proliferation. Contrary, a higher absorbance rate 
show an increase in cell proliferation cell survival is 
almost 50% after 24 h of incubation with Cu(II) 
complexes (compounds 4, 8) (Fig. 7). The anticancer 
results of complexes revealed that Cu(II) complexes 
(compounds 4, 8) exhibit significant cytotoxic effect. 
The IC50 value and percentage of inhibition of Cu(II) 
complexes (compounds 4, 8) are given in Table 2. 
 
Conclusions 
Macrocyclic binuclear metal complexes of 
compounds 2, 3, 4, 6, 7 and 8 of terephthalaldehyde 
with 2-amino 4-chlorophenol and X (X = 2-amino 4-
methylphenol, 2-aminophenol) were synthesized, 
characterised by using physicochemical techniques 
and various spectroscopic studies. The spectral data 
showed that the all metal complexes are four 
coordinated and possess square planar structure 
around the metal ion. The antibacterial, antioxidant 
and DNA cleavage activity of the metal complexes 
reveal more potent than the free ligands. The 
antitumour and DNA binding studies of Cu(II) 
complexes of compounds 4, 8 have significant 
activity. The Cu(II) complexes gives the more 
biological efficiency of the above biological activites 
(antimicrobial, DNA cleavage, binding, antioxidant 
 
Fig. 7 — DNA cleavage studies of (a) ligands (1 and 2) and
(b) their metal (Co(II), Ni(II) and Cu(II)) complexes 




and antitumour) when compared to study of all 
binuclear Co(II) and Ni(II) complexes. 
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